Canada Telemedicine Market By Component (Services & Software, Hardware), By Deployment Mode (Cloud, On-Premises), By Type (Tele-Hospitals, mHealth, and Tele-Homes), By Application (Tele-Psychiatry, General Consultations, Tele-Radiology, Tele-Pathology, and Others), By End User (Patients, Provider, and Payers), By Region, Competition, Forecast and Opportunities, 2028F
Canada telemedicine market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the rising use of smartphones and the various upcoming mobile platforms. Also, the rising healthcare expenditure, technological innovations, rising demand for remote patient monitoring, and the growing burden of chronic diseases is anticipated to drive the growth of the Canada telemedicine market during the forecast period. Rising level of government support and cost benefits of tele-health solutions will influence the growth of Canada telemedicine market during the forecast period. Similarly, major players are focusing on research and development to develop innovative digital diagnostic techniques which will further propel the growth of Canada telemedicine market over the years.
Increasing demand for remote healthcare services
The increasing demand for remote healthcare services is a significant driver of the growth of the Canada telemedicine market. As the population in Canada ages and chronic disease continue to rise, there is a growing need for remote healthcare services, especially for those living in rural and remote areas where access to healthcare facilities can be limited. Telemedicine offers a convenient and efficient way for healthcare providers to offer virtual consultations, remote monitoring, and digital diagnosis to patients, regardless of their location. Telemedicine allows healthcare providers to remotely monitor patients' health conditions, reducing the need for in-person visits and hospitalization. Patients can receive medical care without the need to travel long distances or wait for appointments, making healthcare services more accessible and convenient. The COVID-19 pandemic has further accelerated the demand for remote healthcare services in Canada. With physical distancing measures and restrictions on in-person healthcare services, many healthcare providers have turned to telemedicine to provide remote healthcare services to their patients. This has led to increased awareness and acceptance of telemedicine among healthcare providers and patients.
Advancement in technology
Advancements in technology are a significant driver of the growth of the Canada telemedicine market. With the evolution of technology, telemedicine has become more accessible, affordable, and user-friendly, making it easier for healthcare providers to adopt this technology. The development of mobile health applications has made it possible for patients to receive medical advice and treatment through their smartphones. Mobile health applications allow patients to access healthcare services from anywhere at any time, making healthcare more convenient and accessible.
Wearable devices such as smartwatches and fitness trackers can monitor patients' health conditions and transmit data to healthcare providers in real-time. It allows healthcare providers to remotely monitor patients' health conditions and intervene if necessary, improving the efficiency of healthcare delivery. Remote monitoring devices such as blood glucose monitors and blood pressure monitors can provide patients with real-time data on their health conditions. Healthcare providers can use this data to make informed decisions about patients' treatment plans, reducing the need for in-person consultations. Artificial intelligence(AI) technology is being used to develop predictive analytics tools that can help healthcare providers make more accurate diagnosis and treatment decisions. AI can analyze patient data and provide healthcare providers with insights into patients' health conditions, improving the quality of care.
Impact of covid 19 pandemic
The COVID-19 pandemic has had a significant impact on the growth of the Canada telemedicine market. With physical distancing measures and restrictions on in-person healthcare services, telemedicine has become an essential tool for healthcare providers to provide remote healthcare services to their patients. The pandemic accelerated the adoption of telemedicine, creating a significant opportunity for the Canada Telemedicine market to grow. The pandemic has highlighted the need for telemedicine services, especially for those living in remote and underserved areas where access to healthcare facilities can be limited. Telemedicine has made it possible for healthcare providers to provide medical care to patients regardless of their location, improving access to healthcare services.
The pandemic has led to increased awareness and acceptance of telemedicine among healthcare providers and patients. Healthcare providers had to adapt to new ways of delivering healthcare services, and telemedicine has emerged as a viable option for providing remote healthcare services. Patients have become more comfortable with using telemedicine services, realizing the convenience and benefits of receiving healthcare services from the comfort of their homes. The pandemic has led to changes in government policies and regulations to promote the adoption of telemedicine. The government has provided funding to support the adoption of telemedicine, and regulatory barriers to telemedicine have been reduced to facilitate its adoption.
Government support
Government support is a significant driver of the growth of the Canada telemedicine market. The government plays a crucial role in promoting the adoption of telemedicine by providing funding, creating policies, and removing regulatory barriers to telemedicine adoption. The government has provided funding to support the adoption of telemedicine by healthcare providers. For instance, the Canadian government has provided funding to support the deployment of telemedicine technologies in rural and remote areas, enabling patients to access healthcare services remotely. The government has created policies to promote the adoption of telemedicine. For instance, in 2020, the government of Canada announced new policies to expand virtual care services in response to the COVID-19 pandemic. The policies include expanding the list of virtual care services that are covered under the public healthcare system and reducing regulatory barriers to telemedicine adoption. The government has worked to remove regulatory barriers to telemedicine adoption. For instance, the College of Physicians and Surgeons of Ontario has reduced regulatory barriers to telemedicine adoption, allowing healthcare providers to use telemedicine technologies to deliver medical care to their patients.
Cost savings
Cost savings are a significant driver for the growth of the Canada telemedicine market. Telemedicine offers significant cost savings compared to traditional in-person healthcare services. Telemedicine eliminates the need for patients to travel to healthcare facilities, reducing transportation costs. It reduces the need for healthcare providers to invest in expensive medical equipment, infrastructure, and facilities. Telemedicine improves the efficiency of healthcare delivery, reducing the amount of time healthcare providers spend on administrative tasks such as scheduling appointments and managing paperwork. This improves the productivity of healthcare providers, allowing them to see more patients and generate more revenue. Telemedicine reduces the need for hospital admissions and emergency room visits, which are typically more expensive than regular medical appointments. By providing remote medical consultations and monitoring, telemedicine can help prevent medical complications and hospital admissions, reducing healthcare costs. Telemedicine can help improve patient outcomes, reducing the need for additional medical interventions and hospital admissions, which can lead to cost savings.
Market Segmentation
Canada Telemedicine Market can be segmented by component, deployment mode, type, application, end user, and region. Based on component, Canada telemedicine market can be divided into services & software and hardware. Based on deployment mode, Canada telemedicine market can be divided into cloud and on-premises. Based on type, Canada telemedicine market can be segmented into tele-hospitals, mhealth, and tele-homes. Based on application, Canada telemedicine market can be segmented into tele-psychiatry, general consultations, tele-radiology, tele-pathology, and others. Based on end user, Canada telemedicine market can be segmented into patients, provider, and payers. Regionally, Canada telemedicine market can be categorized into Ontario, Quebec, Alberta, British Columbia, Saskatchewan and Manitoba, and rest of Canada.
Market Players
LifeWatch Technologies Inc, Honeywell Ltd/Canada., Hoffmann-La Roche Ltd, Cisco Systems Canada Co, McKesson Corp., AMD Telemedicine Inc., Teladoc Health Inc., MDLIVE Inc, Medtronic of Canada Ltd. are some of the leading players operating in the Canada Telemedicine Market.
Report Scope:
In this report, the Canada Telemedicine market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present Canada Telemedicine Market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
Increasing demand for remote healthcare services
The increasing demand for remote healthcare services is a significant driver of the growth of the Canada telemedicine market. As the population in Canada ages and chronic disease continue to rise, there is a growing need for remote healthcare services, especially for those living in rural and remote areas where access to healthcare facilities can be limited. Telemedicine offers a convenient and efficient way for healthcare providers to offer virtual consultations, remote monitoring, and digital diagnosis to patients, regardless of their location. Telemedicine allows healthcare providers to remotely monitor patients' health conditions, reducing the need for in-person visits and hospitalization. Patients can receive medical care without the need to travel long distances or wait for appointments, making healthcare services more accessible and convenient. The COVID-19 pandemic has further accelerated the demand for remote healthcare services in Canada. With physical distancing measures and restrictions on in-person healthcare services, many healthcare providers have turned to telemedicine to provide remote healthcare services to their patients. This has led to increased awareness and acceptance of telemedicine among healthcare providers and patients.
Advancement in technology
Advancements in technology are a significant driver of the growth of the Canada telemedicine market. With the evolution of technology, telemedicine has become more accessible, affordable, and user-friendly, making it easier for healthcare providers to adopt this technology. The development of mobile health applications has made it possible for patients to receive medical advice and treatment through their smartphones. Mobile health applications allow patients to access healthcare services from anywhere at any time, making healthcare more convenient and accessible.
Wearable devices such as smartwatches and fitness trackers can monitor patients' health conditions and transmit data to healthcare providers in real-time. It allows healthcare providers to remotely monitor patients' health conditions and intervene if necessary, improving the efficiency of healthcare delivery. Remote monitoring devices such as blood glucose monitors and blood pressure monitors can provide patients with real-time data on their health conditions. Healthcare providers can use this data to make informed decisions about patients' treatment plans, reducing the need for in-person consultations. Artificial intelligence(AI) technology is being used to develop predictive analytics tools that can help healthcare providers make more accurate diagnosis and treatment decisions. AI can analyze patient data and provide healthcare providers with insights into patients' health conditions, improving the quality of care.
Impact of covid 19 pandemic
The COVID-19 pandemic has had a significant impact on the growth of the Canada telemedicine market. With physical distancing measures and restrictions on in-person healthcare services, telemedicine has become an essential tool for healthcare providers to provide remote healthcare services to their patients. The pandemic accelerated the adoption of telemedicine, creating a significant opportunity for the Canada Telemedicine market to grow. The pandemic has highlighted the need for telemedicine services, especially for those living in remote and underserved areas where access to healthcare facilities can be limited. Telemedicine has made it possible for healthcare providers to provide medical care to patients regardless of their location, improving access to healthcare services.
The pandemic has led to increased awareness and acceptance of telemedicine among healthcare providers and patients. Healthcare providers had to adapt to new ways of delivering healthcare services, and telemedicine has emerged as a viable option for providing remote healthcare services. Patients have become more comfortable with using telemedicine services, realizing the convenience and benefits of receiving healthcare services from the comfort of their homes. The pandemic has led to changes in government policies and regulations to promote the adoption of telemedicine. The government has provided funding to support the adoption of telemedicine, and regulatory barriers to telemedicine have been reduced to facilitate its adoption.
Government support
Government support is a significant driver of the growth of the Canada telemedicine market. The government plays a crucial role in promoting the adoption of telemedicine by providing funding, creating policies, and removing regulatory barriers to telemedicine adoption. The government has provided funding to support the adoption of telemedicine by healthcare providers. For instance, the Canadian government has provided funding to support the deployment of telemedicine technologies in rural and remote areas, enabling patients to access healthcare services remotely. The government has created policies to promote the adoption of telemedicine. For instance, in 2020, the government of Canada announced new policies to expand virtual care services in response to the COVID-19 pandemic. The policies include expanding the list of virtual care services that are covered under the public healthcare system and reducing regulatory barriers to telemedicine adoption. The government has worked to remove regulatory barriers to telemedicine adoption. For instance, the College of Physicians and Surgeons of Ontario has reduced regulatory barriers to telemedicine adoption, allowing healthcare providers to use telemedicine technologies to deliver medical care to their patients.
Cost savings
Cost savings are a significant driver for the growth of the Canada telemedicine market. Telemedicine offers significant cost savings compared to traditional in-person healthcare services. Telemedicine eliminates the need for patients to travel to healthcare facilities, reducing transportation costs. It reduces the need for healthcare providers to invest in expensive medical equipment, infrastructure, and facilities. Telemedicine improves the efficiency of healthcare delivery, reducing the amount of time healthcare providers spend on administrative tasks such as scheduling appointments and managing paperwork. This improves the productivity of healthcare providers, allowing them to see more patients and generate more revenue. Telemedicine reduces the need for hospital admissions and emergency room visits, which are typically more expensive than regular medical appointments. By providing remote medical consultations and monitoring, telemedicine can help prevent medical complications and hospital admissions, reducing healthcare costs. Telemedicine can help improve patient outcomes, reducing the need for additional medical interventions and hospital admissions, which can lead to cost savings.
Market Segmentation
Canada Telemedicine Market can be segmented by component, deployment mode, type, application, end user, and region. Based on component, Canada telemedicine market can be divided into services & software and hardware. Based on deployment mode, Canada telemedicine market can be divided into cloud and on-premises. Based on type, Canada telemedicine market can be segmented into tele-hospitals, mhealth, and tele-homes. Based on application, Canada telemedicine market can be segmented into tele-psychiatry, general consultations, tele-radiology, tele-pathology, and others. Based on end user, Canada telemedicine market can be segmented into patients, provider, and payers. Regionally, Canada telemedicine market can be categorized into Ontario, Quebec, Alberta, British Columbia, Saskatchewan and Manitoba, and rest of Canada.
Market Players
LifeWatch Technologies Inc, Honeywell Ltd/Canada., Hoffmann-La Roche Ltd, Cisco Systems Canada Co, McKesson Corp., AMD Telemedicine Inc., Teladoc Health Inc., MDLIVE Inc, Medtronic of Canada Ltd. are some of the leading players operating in the Canada Telemedicine Market.
Report Scope:
In this report, the Canada Telemedicine market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Canada Telemedicine Market, By Component:
- Services & Software
- Hardware
- Canada Telemedicine Market, By Deployment Mode:
- Cloud
- On-Premises
- Canada Telemedicine Market, By Type:
- Tele-Hospitals
- mHealth
- Tele-Homes
- Canada Telemedicine Market, By Application:
- Tele-Psychiatry
- General Consultations
- Tele-Radiology
- Tele-Pathology
- Others
- Canada Telemedicine Market, By End User:
- Patients
- Provider
- Payers
- Canada Telemedicine Market, By Region:
- Ontario region
- Quebec region
- Alberta region
- British Columbia region
- Saskatchewan and Manitoba region
- Rest of Canada
Company Profiles: Detailed analysis of the major companies present Canada Telemedicine Market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Types
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. VOICE OF CUSTOMER
5. CANADA TELEMEDICINE MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Component (Services & Software, Hardware)
5.2.2. By Deployment Mode (Cloud, On-Premises)
5.2.3. By Type (Tele-Hospitals, mHealth, Tele-Homes)
5.2.4. By Application (Tele-Psychiatry, General Consultations, Tele-Radiology, Tele-Pathology, Others)
5.2.5. By End User (Patients, Provider, Payers)
5.2.6. By Region (Quebec, Ontario, Alberta, British Columbia, Saskatchewan & Manitoba, Rest of Canada)
5.2.7. By Company (2022)
5.3. Market Map
6. CANADA TELE HOSPITALS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Component
6.2.2. By Deployment Mode
6.2.3. By Application
6.2.4. By End User
7. CANADA TELE HOMES MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Component
7.2.2. By Deployment Mode
7.2.3. By Application
7.2.4. By End User
8. CANADA MHEALTH MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Component
8.2.2. By Deployment Mode
8.2.3. By Application
8.2.4. By End User
9. MARKET DYNAMICS
9.1. Drivers
9.2. Challenges
10. MARKET TRENDS & DEVELOPMENTS
10.1. Merger & Acquisition
10.2. Product Development
10.3. Recent Developments
11. POLICY & REGULATORY LANDSCAPE
12. PORTERS FIVE FORCES ANALYSIS
12.1. Competition in the Industry
12.2. Potential of New Entrants
12.3. Power of Suppliers
12.4. Power of Customers
12.5. Threat of Substitute Products
13. CANADA ECONOMIC PROFILE
14. COMPETITIVE LANDSCAPE
14.1. Business Overview
14.2. Company Snapshot
14.3. Products & Services
14.4. Financials (As Reported)
14.5. Recent Developments
14.5.1. LifeWatch Technologies Inc
14.5.2. Honeywell Ltd/Canada.
14.5.3. Hoffmann-La Roche Ltd
14.5.4. Cisco Systems Canada Co
14.5.5. McKesson Corp.
14.5.6. AMD Telemedicine Inc.
14.5.7. Teladoc Health Inc.
14.5.8. MDLIVE Inc
14.5.9. Medtronic of Canada Ltd.
15. STRATEGIC RECOMMENDATIONS
About Us & Disclaimer
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Types
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. VOICE OF CUSTOMER
5. CANADA TELEMEDICINE MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Component (Services & Software, Hardware)
5.2.2. By Deployment Mode (Cloud, On-Premises)
5.2.3. By Type (Tele-Hospitals, mHealth, Tele-Homes)
5.2.4. By Application (Tele-Psychiatry, General Consultations, Tele-Radiology, Tele-Pathology, Others)
5.2.5. By End User (Patients, Provider, Payers)
5.2.6. By Region (Quebec, Ontario, Alberta, British Columbia, Saskatchewan & Manitoba, Rest of Canada)
5.2.7. By Company (2022)
5.3. Market Map
6. CANADA TELE HOSPITALS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Component
6.2.2. By Deployment Mode
6.2.3. By Application
6.2.4. By End User
7. CANADA TELE HOMES MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Component
7.2.2. By Deployment Mode
7.2.3. By Application
7.2.4. By End User
8. CANADA MHEALTH MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Component
8.2.2. By Deployment Mode
8.2.3. By Application
8.2.4. By End User
9. MARKET DYNAMICS
9.1. Drivers
9.2. Challenges
10. MARKET TRENDS & DEVELOPMENTS
10.1. Merger & Acquisition
10.2. Product Development
10.3. Recent Developments
11. POLICY & REGULATORY LANDSCAPE
12. PORTERS FIVE FORCES ANALYSIS
12.1. Competition in the Industry
12.2. Potential of New Entrants
12.3. Power of Suppliers
12.4. Power of Customers
12.5. Threat of Substitute Products
13. CANADA ECONOMIC PROFILE
14. COMPETITIVE LANDSCAPE
14.1. Business Overview
14.2. Company Snapshot
14.3. Products & Services
14.4. Financials (As Reported)
14.5. Recent Developments
14.5.1. LifeWatch Technologies Inc
14.5.2. Honeywell Ltd/Canada.
14.5.3. Hoffmann-La Roche Ltd
14.5.4. Cisco Systems Canada Co
14.5.5. McKesson Corp.
14.5.6. AMD Telemedicine Inc.
14.5.7. Teladoc Health Inc.
14.5.8. MDLIVE Inc
14.5.9. Medtronic of Canada Ltd.
15. STRATEGIC RECOMMENDATIONS
About Us & Disclaimer
